Alder BioPharma (ALDR) Updates on CGRP Antagonist Patent Suit vs. Teva's (TEVA) Labrys Biologics
Tweet Send to a Friend
Alder BioPharma (NASDAQ: ALDR) disclosed the following in a U.S. SEC filing on Monday:Item 1.01 Entry into a Material Definitive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
